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Introduction
In this article, we will discuss an important but under-
recognized topic in nephrology. Indeed, indexing glomeru-
lar filtration rate (GFR) for body surface area (BSA) is often
done by habit, because everyone does it and without rais-
ing any questions. Only a scant literature on this topic has
been published in recent decades. Regarding guidelines on
estimating and measuring GFR, only the Australian ones
deeply discuss this topic. However, indexing GFR is not
free from criticisms and may be misleading, especially in
some specific populations. As we have pointed out, index-
ing GFR for BSA has very limited consequences on GFR
results in a ‘normal’ body size population, but its conse-
quences are substantial in other populations such as obese
or anorectic patients [1,2]. In this editorial, we would like
to show the limitations of such an indexation and give some
evidence of its inadequacy.
Indexing GFR for BSA: the genesis
The original article regarding indexation of GFR for BSA
was published in 1928 byMcIntosh [3]. This authorwas also
the first to use the factor ‘1.73m2’ for that indexation,which
is itself questionable, as it has been elegantly shown byHeaf
[4]. McIntosh compared renal function, as urea clearance,
in 18 adults and 8 children. Indexing GFR for BSA gave
comparable urea clearance results between children and
adults [3]. In other words, the values for GFR became less
dispersed by the indexation. These data were confirmed
in 1931 by Holten who studied 90 children and adoles-
cents using creatinine clearance [5]. However, decreasing
the dispersion of the data is not a strong argument for BSA
indexing [6]. McIntosh had also built his indexation the-
ory with experience from earlier American physiological
studies [3]. In 1923, Taylor described an ‘approximately’
direct correlation between urea excretion and the weight
of the kidney in 23 rabbits [7]. Parenthetically, ‘approxi-
mate’ correlations would not pass muster today. This author
also described a better correlation between kidney weight
and BSA than between kidney weight and animal’s weight.
Such a conclusion had also been made by Stewart on a
limited number of dogs [8]. We have re-calculated this cor-
relation with data given by Taylor in his original article
and noted that the correlation between BSA and kidney
weight (r = 0.94) was not different from that between kid-
ney weight and body weight (r = 0.96). In 1932, MacKay
illustrated a direct correlation between BSA and kidney
weight and between BSA and urea excretion in humans [9].
From these observations, McIntosh concluded that BSA
was strongly correlated with renal function [3]. However,
this conclusion may be viewed as too optimistic, as BSA
had not been directly compared to GFR, but just to urea ex-
cretion. Holten described a correlation between creatinine
clearance and BSA, but he thought that this relationship
was not direct but linked to the common relation to basal
metabolic rate (BMR). He based this hypothesis on stud-
ies showing that thyroidectomy decreased kidney weight
on one hand and that giving thyroid hormones increased
protein metabolism and kidney weight on the other hand
[5]. This ‘BMR’ hypothesis has recently been reviewed by
Singer [10].
Whatever the equivalences that were used (kidney func-
tion = urea excretion = kidney weight = BSA), this theory
received great success [3]. Once again, the decreased dis-
persion of the data was a ‘proof’ of the performance of
the BSA indexing. Nevertheless, this argument may lead to
some curiosities. Thus, indexingGFR forBSA leads toGFR
values that are comparable between adults and children. In
newborns, GFRs indexed for BSA are classically lower and
several authors argue that it is linked to the time of matura-
tion for the kidneys [11–16]. This concept of kidney matu-
ration is based on GFR measurements because histological
studies on healthy babies have not been done [13]. Never-
theless, the way the GFR is indexed in babies will influence
the time of the maturation. This was shown by Rubin in
1949: GFR values in children are similar to adults’ values at
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Fig. 1. Illustration of mathematical prerequisites for the use of BSA
indexing.
2 years if GFR is indexed for BSA, at 5 months if indexed
for kidney weight, before 6 months if body weight is used
and after several years if BMR or height is used for indexa-
tion. Rubin finally favoured for indexation BSA because ‘it
is most commonly used in the literature’, a disappointing
argument [16]. The argument of ‘decreasing dispersion of
data’ is thus questionable but can also cynically be used
against the indexation. Indeed, indexing GFR for BSA or
height induces differences in GFR normal values between
men and women (logically as men are heavier and higher)
that will fully disappear if absolute GFR is used [17]. It is
also interesting to underline that differences of GFR normal
values are identical in men and women if GFR is indexed
for extracellular volume fluid (ECFV) [18]. Although the
subject is complex, differences of GFR between genders
have been advanced by some authors as an illustration of
the fallacy of the BSA indexation [17,18].
The true ‘mathematical’ evidence that could justify the
use of indexing for BSA is well known and easy to under-
stand [1,17]. Firstly, the relationship betweenGFR andBSA
must be strong and linear, with a slope not different from 1.
The correlation line must pass through the 0 point, without
an intercept. Secondly, the relationship between GFR and
BSA must totally disappear when GFR is indexed for BSA
(Figure 1). Actually, such prerequisites are not found in the
literature [17,19–23]. Confirmation of these prerequisites
will require the study of a very large sample of ‘nephrolog-
ically’ healthy subjects (including lean and obese), which
would be difficult. We will thus advance indirect evidence.
Indexing GFR for BSA is misleading: reductio ad
absurdum from the study of ‘abnormal body size’
patients
Several theoretical arguments do exist against the use of
BSA indexing. The inadequacy of such use is, however, dif-
ficult to describe in normal body size populations because
in them, indexation has nearly no consequences on GFR
Table 1. Bias induced by the MDRD study equation in an obese popula-







Obesity (n = 81, GFR
over 60 mL/min)
+14 ± 18 mL/
min/1.73 m2
−11 ± 20 mL/min
results [1]. We have thus studied two different abnormal
body size populations, i.e. obese and anorectic patients. We
will use the topic of estimating GFR by creatinine-based
equations (and especially the MDRD study equation) to
illustrate our hypothesis [24,25].
First, GFR and creatinine have been measured in 100
obese patients. Of these 100 patients, only patients with
measured GFR >60 mL/min were considered for analy-
sis (n = 81). Most of these patients were hospitalized for
weight reduction. They were frankly obese as their mean
weight and body mass index (BMI) were 113 ± 28 kg
(range: 76–258 kg) and 41 ± 9 kg/m2, respectively. The
mean absolute GFR was 101 ± 24 mL/min (measured with
the plasma clearance of Cr-EDTA [26]) although the mean
indexed GFR was 76 ± 16 mL/min/1.73 m2 (mean differ-
ence between absolute and indexed: 25 ± 14 mL/min). The
mean serum creatinine (measured with an IDMS traceable
method, the compensated Jaffe´ method from Roche) was
0.80 ± 0.23 mg/dL. Estimated GFR with the MDRD study
equation [GFR = 175 × creatinine−1.154 × age−0.203 ×
0.742 (if woman)] in this population was 90 ± 22 mL/
min/1.73 m2. If absolute GFR is used as the reference,
the MDRD study equation underestimates measured GFR
(mean difference: −11 ± 20 mL/min). If the indexed GFR
is used as the reference, the MDRD equation overestimates
measured GFR (mean difference: + 14 ± 18 mL/min/
1.73 m2) (Table 1). Using indexed GFR as reference, the
MDRD study equation will overestimate GFR results in
our obese population. Although obese, all the patients in-
cluded have a measured GFR >60 mL/min. From several
studies, it can be concluded that the MDRD study equa-
tion systematically underestimates GFR in healthy subjects
(and in subjects with ‘normal’ or ‘near normal’ creatinine
levels) [24,27,28]. There are no good reasons to believe
that this well-established underestimation in low creati-
nine values does not occur in the obese population. In the
same way, there is no reason to believe that the creatinine-
basedMDRD equation overestimates measured GFR in this
population, as it is the case when indexed GFR is consid-
ered. GFR underestimation by the MDRD equation is only
found in our obese patients when absolute GFR measure-
ments are used. In other words, if indexed GFR is used, we
have to conclude that the MDRD study equation overesti-
mates GFR in healthy obese subject, which is astonishing.
If absolute GFR is used, our conclusion will be that this
equation underestimates GFR in these subjects, which is
expected. It could be argued that the MDRD study equation
includes BSA indexation and that back-correction is neces-
sary using Dubois’ formula [29]. In the MDRD study, the
mean weight was 79.6 ± 16.8 kg [25]. In our former work
[1], we have clearly shown that BSA correction has little
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influence on GFR results in non-obese patients. However,
using this formula, developed and adapted for non obese
patients, re-correcting its results by BSAwith obese param-
eters and asserting that the result represents non-corrected
GFR are thus a nonsense.
Another example of BSA inadequacy can be done with
the other ‘extreme population’, i.e. anorectic patients [2].
GFR was systematically measured in 27 patients with
anorexia nervosa. As expected, the population was young
(30 ± 13 years old) and very thin (mean weight: 42 ±
7 kg, mean BMI: 15 ± 2 kg/m2). The mean measured GFR
was 68 ± 23 mL/min and the GFR range was large (13–
134 mL/min), if absolute GFRwas used. In this population,
the serum creatinine has a very poor sensitivity to detect
GFR < 60 mL/min/1.73 m2. Fifty six percent of sensitiv-
ity means that one anorectic patient out of two will have
kidney disease with serum creatinine in the normal range
[2]. This lack of sensitivity is not surprising because serum
creatinine concentration is largely dependent on muscular
mass, as creatinine is the catabolite of the muscular protein
creatine [30]. Because anorectic patients have a decreased
muscular mass, their serum creatinine will not rise as ex-
pected in renal failure. Now, we are showing our results if
indexed GFR for BSA is used in place of absolute GFR.
In this condition, mean indexed GFR is logically higher
(80 mL/min/1.73 m2 versus 68 ± 23 mL/min if abso-
lute GFR). The creatinine sensitivity (determined by ROC
curves) to detect GFR< 60 mL/min/1.73 m2 would be also
higher, i.e. 75%. Based on the well-known creatinine sensi-
tivity in the general population, the sensitivity of creatinine
in this anorectic population could be seen as good (or even
better) than of the ‘normal’ body size population [2,31].
This is not possible.
Our last example comes from the recent study of
Moranne et al. [32]. In their large sample (n = 1038),
the authors have studied the impact of GFR on chronic kid-
ney disease-related complications. Cr-EDTA was used for
measurement of the GFR. Twenty percent of the popula-
tion was obese (BMI >30 kg/m2). We will focus on one
intriguing result. From their multivariate analysis, the au-
thors found that obesity was associated with a lower risk for
anaemia. The physiological basis for such a conclusion is
questionable. Interestingly, if statistics are done with abso-
lute GFR (and not indexed GFR), the relationship between
obesity and risk of anaemia totally disappears (personal
communication). From our point of view, indexing GFR
will artificially decrease GFR in obese patients. So, obe-
sity will be erroneously considered as a protector against
anaemia in kidney disease although these patients have, in
fact, no kidney disease at all.
Which alternative to BSA indexation?
Which alternative could be proposed in place of BSA in-
dexing? If indexation must be used (which remains to be
proved [6,33]), several ways of indexing have been sug-
gested (reminded in [1]). Among these suggestions, height
and ECFV are the most often considered. Regarding height,
studies have shown that corrected GFR for height is identi-
cal in obese and non-obese populations, whereas corrected
GFR for BSA is inadequately lower in the obese population
[34,35]. However, we have already criticized this kind of
argument (i.e. lowering dispersion of data). As the range
of height in the population is narrower than the range of
weight (giants and dwarfs are less numerous than obese
or anorectic), it is logical that indexing for height will de-
crease dispersion of data in the adult population. However,
it is not sufficient. Indeed, the fundamental prerequisite
(figure 1) has not been studied. Some authors proposed
that GFR must be indexed for ECFV [36–39]. Indeed, it
seems intuitively better to correct GFR for ECFV because
one of the roles of the kidney is to regulate body fluid com-
position. Nevertheless, ECFVs are not so easy to measure.
Indexing GFR for ECFV could only be done when GFR is
measured with urinary clearance [18,40]. Moreover, math-
ematical prerequisites have been poorly studied, too. Peters
et al. argue that using ECFV indexing had excellent re-
producibility on GFR measurement [41], and makes GFR
‘normal’ values identical in male and women [18,37] and in
young infants and adults [38,39]. However, once again, all
these ‘proofs’ are indirect [42]. Even with these limitations
and even if indexing for ECFV is still using a ratio and is
thus ‘mathematically’ questionable [6,33], we agree with
these authors: indexing GFR for ECFV is of interest and
we need additional researches on this topic [1].
Conclusions and perspective
There are several limitations to the use BSA for GFR index-
ation. This indexation could be considered as a myth. In-
deed, it is based on very poor physiological data. Moreover,
we have also shown that this indexation may be misleading.
Applying BSA indexation has a ‘numerical’ effect in the
‘abnormal’ body size population, i.e. patients with extreme
BMI (<18 kg/m2 and >30 kg/m2). This effect is probably
largely overestimated. Moreover, the estimation of BSA by
classical equations is neither precise nor accurate, espe-
cially in obese patients [1,4]. So why use it?
For teaching reasons, we have especially insisted on the
effect of BSA indexation on the extreme body size popu-
lation. However, BSA indexation could have consequences
even in non-obese studies. For example, Bosma et al. have
well illustrated that BMI can be considered as a predictor of
GFR if GFR is indexed for BSA, but not if GFR is indexed
for height [43].
Nowadays, even if other indexations have been pro-
posed [1,18,40], we recommend to use absolute, non-
indexed GFR, especially in ‘abnormal’ body size popu-
lations. Definitive arguments for not using BSA indexation
will come from studies using appropriate statistics [17]
and including a large sample of healthy adults with a large
range of body sizes. For example, the large database of
living kidney donors recently published by Poggio et al.
could certainly be used to study indexation (are the fig-
ure 1 prerequisites met for BSA, or not?) and the effect
of indexation on percentiles of ‘normal’ reference values
[44]. If indexation is not recommended, GFR from children
and adults would not be still comparable. The definition of
‘normal’GFRvaluesmust thusmove from simple ‘cut-offs’
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to percentiles, as it has been shown by Piepsz in children
[40] and suggested by others in adults [44,45].
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